Literature DB >> 3345871

Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli.

S J Konturek1, J Tasler, M Cieszkowski, K Szewczyk, M Hladij.   

Abstract

Exocrine pancreatic response to food is believed to result from the interaction of neural and hormonal factors, but their contribution in the net postprandial secretion is unknown. Recent description of a highly specific and potent cholecystokinin (CCK)-receptor antagonist permitted the evaluation of the physiologic role of CCK in postprandial pancreatic secretion. In dogs with chronic pancreatic fistula, CCK antagonism caused little alteration in sham feeding- or urecholine-induced pancreatic protein secretion, but reduced by approximately 60% the pancreatic protein response to a gastrointestinal meal and virtually abolished the pancreatic responses to duodenal perfusion with amino acids or oleate and to exogenous CCK, but not to secretin or neurotensin. The pancreatic protein responses, particularly to lower doses of gastrin, were also reduced by CCK-receptor antagonist, but no changes in the responses to secretin or neurotensin were detected. Cholecystokinin antagonism also significantly reduced the pancreatic polypeptide responses to CCK, gastrin, and the gastrointestinal meal, possibly due to removal of the CCK-mediated release of pancreatic polypeptide. We conclude that CCK plays a crucial role in the mediation of the gastrointestinal phase, but not the cephalic phase, of pancreatic secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345871     DOI: 10.1016/0016-5085(88)90561-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.

Authors:  J B Jansen; A J de Jong; M V Singer; W Niebel; L C Rovati; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

2.  Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.

Authors:  A Dembinski; J Jaworek; P K Konturek; S J Konturek; Z Warzecha
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

3.  Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons.

Authors:  Huan Zhao; Steven M Simasko
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

4.  Pancreatic secretion evoked by cholecystokinin and non-cholecystokinin-dependent duodenal stimuli via vagal afferent fibres in the rat.

Authors:  Y Li; C Owyang
Journal:  J Physiol       Date:  1996-08-01       Impact factor: 5.182

5.  Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.

Authors:  M Fried; W Schwizer; C Beglinger; U Keller; J B Jansen; C B Lamers
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

6.  CCK receptors in release of pancreatic polypeptide (PP) in dogs.

Authors:  S J Konturek; P Konturek; W Bielański; K Szewczyk
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

7.  Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.

Authors:  A J de Jong; M V Singer; J B Jansen; W Niebel; L C Rovati; C B Lamers
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

8.  Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.

Authors:  Y Moriyoshi; K Shiratori; C Iwabe; S Watanabe; T Takeuchi
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

9.  CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.

Authors:  J W Konturek; S J Konturek; A Kurek; J Bogdal; J Oleksy; L Rovati
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.